Keliximab (SB-210396), a chimeric human/macaque IgG1 anti-CD4 monoclonal antibody, demonstrates a binding affinity for soluble CD4 with a K i value of 1.0 nM. It inhibits T cell proliferation and IL-2 production, making it a valuable agent for cancer research [1] [2].
CAS Number:
[174722-30-6]
Target:
Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted
